Skip to main content
. 2007 Aug 22;45(10):3167–3174. doi: 10.1128/JCM.01143-07

TABLE 6.

Samples resulting in different disease state classifications between DRL and this study

Specimen PRNT90a
P/N valueb
Antigenc Disease state classificationd
IgM
IgG
SLEV WNV DENV-2 SLEV WNV SLEV WNV
57 40 40 1.50 5.31 4.98 4.23 DRL Flavivirus
14.56 1.10 NDe ND WT SLEV
5.00 1.09 ND ND Mutant
98 20 40 3.50 5.50 6.80 4.30 DRL Flavivirus
7.69 10.11 ND ND WT WNV
1.14 3.73 ND ND Mutant
103 5120 2560 5.90 5.00 7.60 15.50 DRL Flavivirus
5.29 7.11 ND ND WT WNV-secondary
4.71 4.91 ND ND Mutant
109 <10 <10 1.20 2.70 4.60 4.60 DRL Recent WNV
5.71 2.55 ND ND WT Unknown flavivirus
1.77 1.93 ND ND Mutant
115 20 160 0.85 2.50 3.60 8.20 DRL Recent WNV
1.03 2.72 ND ND WT Unknown etiology
1.06 2.41 ND ND Mutant
62 <10 <10 10 1.79 1.18 5.71 1.95 DRL Recent SLEV
1.59 1.43 ND ND WT Unknown etiology
1.12 1.31 ND ND Mutant
34 2560 640 6.90 ND 3.60 4.10 DRL Flavivirus
1.93 1.37 ND ND WT Unknown etiology
1.95 1.43 ND ND Mutant
42 20480 1280 3.90 2.00 10.50 3.20 DRL SLEV
1.14 1.74 ND ND WT Unknown etiology
1.18 2.03 ND ND Mutant
93 <10 10 40 1.44 2.07 2.49 3.27 DRL Flavivirus, WNV-secondary
1.08 1.14 ND ND WT Unknown etiology
0.99 1.10 ND ND Mutant
58 20 10 20 2.53 4.72 8.11 7.00 DRL Flavivirus
1.19 1.19 ND ND WT Unknown etiology
1.14 0.99 ND ND Mutant
59 ND ND 2.80 6.52 9.03 8.00 DRL Flavivirus
1.08 1.55 ND ND WT Unknown etiology
0.85 1.06 ND ND Mutant
a

PRNT90, titers represent 90% plaque reduction endpoints reported by the DRL.

b

P/N values of ≥3.0 are shown in boldface.

c

ELISA data are presented from tests with three types of antigen: the DRL antigens, which include both SMB and VLP for WNV and SMB for SLEV; this study's WT VLP antigens; and the mutant antigens with reduced cross-reactivity of both WNV and SLEV.

d

DRL disease state classifications are matched by row with the DRL antigen. Some of the DRL disease state classifications are based partially on additional data not presented in this table.

e

ND, not done.